Prot #CCP-020-101: A Multi-center Study to Evaluate the Pharmacokinetics of Diacerein and Rhein and the Safety of Diacerein After Maximum Use, Topical Administration of CCP-020 (Diacerein 1% ointment) to Patients with Epidermolysis Bullosa (EB)

Project: Research project

Project Details

StatusActive
Effective start/end date5/25/185/25/21

Funding

  • Castle Creek Pharmaceuticals LLC (Prot #CCP-020-101)